The human ovary contains a fixed number of non-growing follicles (NGFs) established before birth that decline with increasing age culminating in the menopause at 50–51 years. The objective of this study is to model the age-related population of NGFs in the human ovary from conception to menopause. Data were taken from eight separate quantitative histological studies (n = 325) in which NGF populations at known ages from seven weeks post conception to 51 years (median 32 years) were calculated. The data set was fitted to 20 peak function models, with the results ranked by obtained correlation coefficient. The highest ranked model was chosen. Our model matches the log-adjusted NGF population from conception to menopause to a five-parameter asymmetric double Gaussian cumulative (ADC) curve ( = 0.81). When restricted to ages up to 25 years, the ADC curve has = 0.95. We estimate that for 95% of women by the age of 30 years only 12% of their maximum pre-birth NGF population is present and by the age of 40 years only 3% remains. Furthermore, we found that the rate of NGF recruitment towards maturation for most women increases from birth until approximately age 14 years then decreases towards the menopause. To our knowledge, this is the first model of ovarian reserve from conception to menopause. This model allows us to estimate the number of NGFs present in the ovary at any given age, suggests that 81% of the variance in NGF populations is due to age alone, and shows for the first time, to our knowledge, that the rate of NGF recruitment increases from birth to age 14 years then declines with age until menopause. An increased understanding of the dynamics of human ovarian reserve will provide a more scientific basis for fertility counselling for both healthy women and those who have survived gonadotoxic cancer treatments.
Citation: Wallace WHB, Kelsey TW (2010) Human Ovarian Reserve from Conception to the Menopause. PLoS ONE 5(1): e8772. doi:10.1371/journal.pone.0008772
Editor: Virginia J. Vitzthum, Indiana University, United States of America
Received: October 13, 2009; Accepted: December 31, 2009; Published: January 27, 2010
Copyright: © 2010 Wallace, Kelsey. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: TWK is supported by United Kingdom Engineering and Physical Sciences Research Council (EPSRC) grants EP/CS23229/1 and EP/H004092/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Our current understanding of human ovarian reserve presumes that the ovary establishes several million non growing follicles (NGFs) at around five months of gestational age which is followed by a decline to the menopause when approximately 1,000 remain at an average age of 50–51 years , . With approximately 450 ovulatory monthly cycles in the normal human reproductive lifespan, this progressive decline in NGF numbers is attributed to follicle death by apoptosis.
A number of recent reports have challenged this long held understanding of mammalian reproductive biology by reporting the presence of mitotically-active germ stem cells in juvenile and adult mouse ovaries –. While the presence of germ stem cells within the mammalian ovary that are capable of neo-oogenesis remains controversial , , a better understanding of the establishment and decline of the NGF population will be important in determining if neo-oogenesis occurs as part of normal human physiological ageing.
Several studies have reported the number of NGFs at different ages in humans – and constructed mathematical models of NGF decline , , . Some of these studies have suggested that the instantaneous rate of temporal change increases around the age of 37 years, when approximately 25,000 follicles remain, followed by exhaustion of the NGF pool and menopause 12–14 years later , . These studies have addressed the decline from birth of the NGF population, but none has included the crucial establishment phase from conception to a peak at 18–22 weeks gestation. Our study uses more histological data than any previous study, and includes data from prenatal ovaries, allowing us to analyse complete models involving both population establishment and decline. The objective of our study is to identify the most robust mathematical model to describe the establishment and decline of NGFs in the human ovary from conception to menopause. This will allow us to estimate the number of NGFs present at a given age and describe the rate of recruitment of NGFs towards maturation or apoptosis with increasing age.
The Best Fitting Peak Model
The highest ranked model ( = 0.81) returned by the search for the best fitting model to the 325 data-points was a 5-parameter asymmetric double-Gaussian cumulative (ADC) curve (Equation (1)). The first 3 parameters, (, and ) define the scale and amplitude of the curve; the remaining parameters ( and ) define the rates of population establishment and decline.(1)
The values for the parameters that maximise the correlation coefficient for our dataset are given in Equation (2). The model is asymmetric, since rapid establishment is followed by a long period of decline ( is small and is large); it is double-Gaussian cumulative since it is the product of two Gauss-error functions.(2)
This model (illustrated graphically in Figure 1) demonstrates that 81% of the variation in individual NGF populations is due to age alone. Full statistical analysis and derivation details for the model are given in additional file 1. Interestingly, if we confine our analysis to the histological data from conception to age 25 years we discover that the ADC model remains the best fit ( = 0.95) and that 95% of the variation in NGF numbers is due to age alone (Figure 2).
Figure 1. The model that best fits the histological data.
The best model for the establishment of the NGF population after conception, and the subsequent decline until age at menopause is described by an ADC model with parameters = 5.56 (95% CI 5.38–5.74), = 25.6 (95% CI 24.9–26.4), = 52.7 (95% CI 51.1–54.2), = 0.074 (95% CI 0.062–0.085), and = 24.5 (95% CI 20.4–28.6). Our model has correlation coefficient = 0.81, fit standard error = 0.46 and F-value = 364. The figure shows the dataset (n = 325), the model, the 95% prediction limits of the model, and the 95% confidence interval for the model. The horizontal axis denotes age in months up to birth at age zero, and age in years from birth to 51 years.doi:10.1371/journal.pone.0008772.g001
Figure 2. The model that best fits the histological data for ages up to 25 years.
The best model for the establishment of the NGF population after conception, and the subsequent decline until 25 years of age is described by an ADC model with parameters = 5.79 (95% CI 5.03–6.55), = 28.0 (95% CI 15.8–40.2), = 57.4 (95% CI 33.1–81.8), = 0.074 (95% CI 0.067–0.081), and = 34.3 (95% CI −4.2–72.8). This model has correlation coefficient = 0.95, fit standard error = 0.29 and F-value = 585. This figure shows the dataset (n = 126), the model, the 95% prediction limits of the model, and the 95% confidence interval for the model. The horizontal axis denotes age in months up to birth at age zero, and age in years from birth to 25 years.doi:10.1371/journal.pone.0008772.g002
To guard against model selection bias and to test the robustness of the model with respect to the data, we randomly removed 50 data points 61 times and re-fitted the models, with the ADC model being, on average, the best fitting model (double-sided t-test for difference of means, ). Additional file 2 gives details of the statistical tests performed.
Models That Allow Neo-Oogenesis
To examine whether a model that permits neo-oogenesis would provide a better fit to the data, we further analysed the data by fitting models that need be neither asymmetric nor single peak. We found that any mathematical model that permits an increase in NGF population after the peak at 18–22 weeks has a markedly inferior fit compared to the best-fitting ADC model (Figure 3).
Figure 3. The highest ranked model that allows growth after the initial peak.
The highest-ranked non-peak model returned by TableCurve is a polynomial given by . Compared to the ADC model for the same data, the model has lower correlation coefficient, higher fit standard error, and lower F-statistic. All other TableCurve models that allow multiple peaks have an inferior fit to the data.doi:10.1371/journal.pone.0008772.g003
Estimated NGF Population by Age
If menopause is defined as a population of less than one thousand (in line with Faddy & Gosden ), the model predicts age of menopause as 49.6 (95% CI 47.9–51.2) years, with a 95% prediction interval of 38.7–60.0 years (Figure 4). Our model gives a maximum mean NGF population of 300,000 per ovary (95% CI 225,000–390,000), occurring at 18–22 weeks post-conception, with a 95% prediction interval (PI) of 35,000–2,534,000 NGFs. Figure 4 gives values for NGF populations at illustrative ages, together with the corresponding 95% prediction intervals. Women with an average age of menopause will have around 295,000 NGFs present at birth per ovary, with women destined to have an earlier menopause having around 35,000 NGFs and late menopause women having over 2.5 million NGFs per ovary at birth.
Figure 4. Illustrative examples.
This figure gives illustrative examples of NGF populations predicted by our model. At ages 20 weeks, birth, 13 years, 25 years and 35 years the average NGF population is given, together with the respective 95% prediction intervals. The predicted average age at menopause (49.6 years) is also shown, together with the 95% prediction interval.doi:10.1371/journal.pone.0008772.g004
We describe the percentage of the NGF population remaining for a given age for women whose ovarian reserve is established and declines in line with our model (Figure 5). We estimate that for 95% of women by the age of 30 years only 12% of their maximum pre-birth NGF population is present and by the age of 40 years only 3% remains. The hypothesis that early (respectively late) menopause is related to low (respectively high) peak population at 18–22 weeks post conception is illustrated in Figure 6.
Figure 5. Percentage of ovarian reserve related to increasing age.
The curve describes the percentage of ovarian reserve remaining at ages from birth to 55 years, based on the ADC model. 100% is taken to be the maximum ovarian reserve, occurring at 18–22 weeks post-conception. The percentages apply to all women whose ovarian reserve declines in line with our model (i.e. late and early menopause are associated with high and low peak NGF populations, respectively). We estimate that for 95% of women by the age of 30 years only 12% of their maximum pre-birth NGF population is present and by the age of 40 years only 3% remains.doi:10.1371/journal.pone.0008772.g005
Figure 6. A hypothetical link between ovarian reserve and age at menopause.
This figure describes the hypothesis that individual age at menopause is determined by the peak NGF population established at around 20 weeks post-conception. The central curve is the ADC model described in Figures 1 and 4. Above and below are the hypothetical curves for an ovary having log-adjusted peak population varying from the average case by one half, one, one and a half, and two standard deviations. Under this hypothesis, a variation by, for example, one standard deviation in the initial peak population results in a one standard deviation from the average age at menopause.doi:10.1371/journal.pone.0008772.g006
Rates of NGF Recruitment towards Maturation
To investigate the number of NGFs recruited towards maturation and ovulation or apoptosis each month we have solved our model to show (Figure 7a) that the maximum recruitment of 880 NGFs per month occurs at 14 years 2 months for the average age at menopause woman. While the maximum rate of recruitment varies hugely, from around 100 NGFs per month (Figure 7b) to over 7,500 NGFs per month (Figure 7c) for women with an early or late menopause respectively, the rate of NGF recruitment increases to a plateau at just over 14 years and then decreases for women in general irrespective of how many NGFs were established by birth.
Figure 7. Rates of NGF recruitment towards maturation.
Each sub-figure describes the absolute number of NGFs recruited per month, for ages from birth to 55 years, based on population decline predicted by the ADC model. Figure 7 (a) - red curve - denotes recruitment for individuals whose decline is in line with the average age at menopause; maximum recruitment of 880 follicles per month occurs at 14 years 2 months. Figure 7 (b) - green curve - denotes recruitment for individuals whose decline is in line with early age at menopause (the lower 95% prediction limit of the model); maximum recruitment of 104 follicles per month occurs at 14 years 2 months. Figure 7 (c) - yellow curve - denote recruitment in line with late age at menopause (the upper 95% prediction limit of the model); maximum recruitment of 7,520 follicles per month occurs at 14 years 2 months.doi:10.1371/journal.pone.0008772.g007
In this study we have identified the first model of human ovarian reserve from conception to menopause that best fits the combined histological evidence. This model allows us to estimate the number of NGFs present in the ovary at any given age, suggests that 81% of the variance in NGF populations is due to age alone, and shows that the rate of NGF recruitment increases from birth to age 14 years then declines with age until menopause. Further analysis demonstrated that 95% of the NGF population variation is due to age alone for ages up to 25 years. The remaining 5% is due to factors other than age e.g. smoking, BMI, parity and stress. We can speculate that as chronological age increases, factors other than age become more important in determining the rate at which NGFs are lost through apoptosis.
We have made two major assumptions in our study. Firstly, that the results of the eight histological studies that have estimated the total number of NGFs per human ovary are comparable. The definition of a NGF is identical in six of the studies and similar in the remaining two studies. The counting techniques all used a variation of the technique first described by Block . Our assumption is in line with that of Faddy and Gosden who also assumed histological studies to be comparable when deriving a model for ovarian reserve from birth that also took average age at menopause into account . The differences between their 1996 study and our study are that we have used more histological data–including for the first time prenatal data–and that we use known ranges of age at menopause as a check on the validity of our model, rather than a contributing factor. In the eight reported studies, the majority of younger samples were from autopsy and many of the older subjects had undergone surgical oophorectomy. It is possible that this difference in the source of the ovarian samples influences our finding that factors other than age become more important in older women. Other studies, and previously reported models, of ovarian reserve have not made a distinction in the reported source of the material; in particular the Hansen et al. study combined 77 autopsy subjects and 45 elective surgical subjects into a single dataset.
Our second assumption is that the peak number of NGFs at 18–22 weeks gestation defines age at menopause for the individual woman, with early menopause women having low peak populations and late menopause women having high peak populations. The data on the number of NGFs in the ovary is cross-sectional: there is no longitudinal data available and in the absence of a non-invasive test to count NGFs in the individual woman this data is likely to remain unobtainable. Considered together the wide variation at age at menopause and wide variation of peak population of NGFs are suggestive but not conclusive evidence for this assumption to be tenable.
Since the publications by Johnson et al. ,  there has been lively scientific debate around the widely held concept that a non-renewing oocyte reserve is laid down in the ovaries at birth, and that neo-oogenesis does not occur in adult life . Johnson and Tilly have argued that their experiments in the adult female mouse have demonstrated conclusively that neo-oogenesis continues in adulthood. They have proposed that the source of postnatal oocyte production is from germline stem cells in the bone marrow, which are transported in the peripheral circulation as germline progenitor cells to arrive in the adult ovary . The recent report showing isolation and culture of germline stem cells from adult mouse ovaries , which restored fertility after injection into infertile mice, provides further evidence to support the presence of germ line stem cells in mammalian ovaries. Our analysis of the available histological data demonstrates that any mathematical model that permits an increase in NGF population after the peak at 18–22 weeks has a markedly inferior fit compared to the best-fitting asymmetric peak functions. While the emerging evidence strongly supports the existence of germ stem cells within adult mouse ovaries , our model provides no supporting evidence of neo-oogenesis in normal human physiological ageing.
We have described the percentage of the NGF population remaining for a given age for all women whose ovarian reserve is established and declines in line with our model (Figure 5). If we assume that a high initial NGF population is associated with late menopause, and that a low peak NGF population is associated with early menopause, then these percentages apply to 95% of all women. It is important to note that we have shown that by the age of 30 years the percentage NGF population is already 12% of the initial reserve and only 3% of the reserve remains at 40 years of age. A recent study has shown that most women underestimate the extent to which age affects their ability to conceive naturally .
Our finding that the rate of NGF recruitment increases to a plateau at just over 14 years and then decreases in all women irrespective of how many NGFs were established by birth is highly unlikely to be explained by coincidence. From the first comprehensive model of NGF decline from birth  we can calculate that the maximum NGF recruitment occurs at birth (data not shown). However, this model was not only based on goodness of fit to histological data, but it also included adjustments to take known distribution of ages at menopause into account. A more recent model of decline from birth is based entirely on fitting to histological data . For this model we calculate that the maximum recruitment of NGFs to maturation occurs at 18 years 11 months (data not shown).
In western society the average age of menarche is around 13 years , with early breast development appearing around age 11 years. Our data suggests that the onset of oestrogenisation and ovulation heralds a slowing in the rate of NGF recruitment. Our findings suggest that both endocrine and paracrine factors may be important in the slowing and subsequent decline in the rate of NGF recruitment. An important candidate is anti-Müllerian hormone (AMH), a member of the transforming growth factor-beta (TGF-) superfamily of growth factors . They are produced by ovarian granulosa cells and oocytes in a developmental, stage-related manner and function as intra-ovarian regulators of folliculogenesis. There is good evidence that AMH from granulosa cells of pre-antral or antral follicles exerts a negative inhibitory influence on the primordial to primary follicle transition . Furthermore AMH has been proposed as an indirect marker of ovarian reserve in post-pubertal women . Until the onset of puberty (characterised by the switching on of the hypothalamic-pituitary axis and the pulsatile secretion of the gonadotophins FSH and LH) follicular maturation rarely progresses beyond the pre-antral stage. The presence of the pulsatile secretion of FSH and LH at puberty promotes follicular maturation to the antral stage and beyond. There is however incomplete data on AMH levels in pre-pubertal girls in the literature: AMH is undetectable before birth  and is detectable at low levels in infants . The explanation for our finding that the rate of NGF recruitment increases until the onset of puberty, levels off at around 14 years of age, and then declines to the menopause remains unclear. It is interesting to speculate that AMH levels which are undetectable at birth may rise at puberty with the establishment of regular ovulatory cycles and be responsible for the slowing of the rate of NGF recruitment that occurs at puberty.
Can a more complete understanding of the establishment and decline of the non-renewing pool of NGFs help us to assess ovarian reserve for the individual woman? Several candidate markers for the assessment of ovarian reserve in the individual woman have been suggested including FSH, Inhibin B, AMH, and antral follicle counts and ovarian volume by transvaginal ultrasound , . We have previously reported a striking correlation between ovarian volume and NGF population using an earlier model . However the measurement of ovarian volume by transvaginal ultrasound is imprecise, particularly at the lower end of the range . It is likely that a better understanding of NGF establishment and decline will improve our ability to assess ovarian reserve for the individual woman. One immediate application of our model is to better understand the effect of chemotherapy and radiotherapy on the human ovary. Using a model based on less complete histological data, we estimated the radiosensitivity of the human oocyte  and were subsequently able to estimate the effective sterilising dose of radiotherapy at a given age for the individual woman . Knowledge of the dose of radiotherapy and age at which it is delivered provides an important opportunity for accurate counselling of women receiving cancer treatment and will help us to predict which women are at high risk of premature menopause and who may therefore benefit from ovarian cryopreservation .
We have described and illustrated a model of human ovarian reserve from conception to menopause that best fits the combined histological evidence. Our model matches the log-adjusted NGF population to a five-parameter asymmetric double Gaussian cumulative (ADC) curve ( = 0.81). When restricted to ages below 26 years, the ADC curve has = 0.95. We estimate that for 95% of women by the age of 30 years only 12% of their maximum pre-birth NGF population is present and by the age of 40 years only 3% remains. Furthermore, we found that the rate of NGF recruitment towards maturation for most women increases from birth until approximately age 14 years then decreases towards the menopause. An increased understanding of the dynamics of human ovarian reserve will provide a more scientific basis for fertility counselling for both healthy women and those who have survived gonadotoxic cancer treatments.
Histological Studies of NGF Populations
Data were taken from all eight known published quantitative histological studies of the human ovary (Tables 1 and 2). In all eight studies the definition of a NGF is similar. For studies 2,4,5,6,7 & 8 the definition of a NGF is according to the morphological criteria of Block and Gougeon , : an NGF was counted when a clearly defined oocyte nucleolus was present within the optical dissector counting frame. In studies 1 & 3, fetal ovary studies, an NGF was defined as being an oocyte surrounded by a single layer of granulosa cells. Each of these studies used a variation on the technique developed by Block to estimate the NGF population of an ovary . Ovaries are sectioned and some of the sections stained and photographed. A mean NGF volume is calculated from a sample image and used throughout all subsequent calculations. The photographs are analysed by hand, with the number of NGFs appearing in the photograph being counted. By assuming an even distribution throughout the ovary, the population of the samples is integrated into an estimated population for the entire ovary. The studies differ in the stain used, the number of samples chosen, the method of counting, and the mathematical formula used to obtain the estimated population from the sample populations. Some ovaries were obtained at autopsy and some after elective surgical oophorectomy. Older subjects were more likely to have undergone surgical oophorectomy. No standard error has been calculated for such studies, as the exact number of NGFs in a specific ovary has not been calculated. We combined these data into a single dataset (n = 325) and enforced a zero population at conception.
Table 1. The eight quantitative histological studies forming the combined dataset.doi:10.1371/journal.pone.0008772.t001
Table 2. The eight quantitative histological studies of NGF population summarised by ovarian age.doi:10.1371/journal.pone.0008772.t002
We fitted 20 asymmetric peak models to the data set, using TableCurve-2D (Systat Software Inc., San Jose, California, USA), and ranked by correlation coefficient. Each model defines a generic type of curve and has parameters, which, when instantiated gives a specific curve of that type. For each type of curve, we calculated values for the parameters that maximise the for that model. The 20 models supplied by TableCurve are those that are commonly reported in the scientific literature as models of datasets that rise and fall such as pharmacodymanics, cell populations and electromagnetic signals. The Levenberg-Marquardt non-linear curve fitting algorithm was used, with convergence to 15 significant figures in after a maximum of 10,000 iterations. We performed the same analysis on the datapoints associated with an age of 25 years or under. File S1 contains the dataset, the model ranking, the output used to prepare Figures 1 and 2, and the statistics associated with the highest-ranked model.
To avoid selection bias, we randomly removed 50 datapoints 61 times and re-fitted the models, calculating the mean and standard deviations of the coefficients obtained for each model. We then compared the mean obtained for the two highest ranked models for a statistically significant difference. File S2 contains statistics regarding the correlation coefficient for the models obtained in this way, together with output for the test for a statistically significant difference of the two highest means. To further avoid selection bias from our initial choice of models, and to allow the possibility of more than one peak (i.e. to allow models involving regeneration of ovarian reserve), we fitted all 266 models supplied by TableCurve, again ranking by . The highest ranked model was used as the basis for further calculations. Under the modelling assumption that, in general, a high (versus low) established population results in a late (versus early) menopause, we calculated the percentage of NGF pool at given ages, and the absolute monthly loss of germ cells from birth until age 55.
Calculation of Recruitment Rates
To calculate the rates of recruitment of NGFs towards maturation we solved the equations describing the early, late and average menopause models for all months from birth to menopause. The absolute numbers of NGFs recruited were then given by the differences in successive monthly totals.
This file contains (1) a plot of the ADC model that best fits the histological data, (2) full statistics for the model, (3) a plot of the residuals, (4) the dataset with values for the model, the residuals, the 95% CI for the model and the 95% prediction interval, (5) details of the iterations taken to obtain the model, and (6) the ranking of the peak functions as fitted to the dataset.
(0.18 MB PDF)
It may have been a chance result that the ADC performed well on the 325 datapoints selected, and that another model would perform better, in general, on similar datasets. The additional file contains details of the testing of this hypothesis, and shows that the ADC mean r2 was statistically significantly higher than any other peak model (p = 0:0065).
(0.05 MB PDF)
We would like to acknowledge the critical discussions we have had with Prof. Richard Anderson, Prof. Ian Gent, Dr. Jacob Howe, Dr. Dror Meirow and Dr. Evelyn Telfer.
Conceived and designed the experiments: WHW TWK. Performed the experiments: TWK. Analyzed the data: WHW TWK. Wrote the paper: WHW TWK.
- 1. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF (1992) Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Human Reproduction 7: 1342–1346. doi: 10.1098/rspb.1963.0055
- 2. Faddy MJ, Gosden RG (1996) A model conforming the decline in follicle numbers to the age of menopause in women. Human Reproduction 11: 1484–1486. doi: 10.1093/oxfordjournals.humrep.a019422
- 3. Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL (2004) Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 428: 145–150. doi: 10.1038/nature02316
- 4. Johnson J, Bagley J, Skaznik-Wikiel M, Lee HJ, Adams GB, et al. (2005) Oocyte generation in adult mammalian ovaries by putative germ cells derived from bone marrow and peripheral blood. Cell 122: 303–315. doi: 10.1016/j.cell.2005.06.031
- 5. Zou K, Yuan Z, Yang Z, Luo H, Sun K, et al. (2009) Production of offspring from a germline stem cell line derived from neonatal ovaries. Nature Cell Biology 11: 631–636. doi: 10.1038/ncb1869
- 6. Telfer EE, Gosden RG, Byskov AG, Spears N, Albertini D, et al. (2005) On regenerating the ovary and generating controversy. Cell 22: 821–822. doi: 10.1016/j.cell.2005.09.004
- 7. Tilly J, Telfer EE (2009) Purification of germline stem cells from adult mammalian ovaries: a step closer towards control of the female biological clock? Molecular Human Reproduction 15: 393–398. doi: 10.1093/molehr/gap036
- 8. Block E (1951) Quantitative morphological investigations of the follicular system in women: variations at different ages. Acta Anatomica 14: 108–123. doi: 10.1159/000140595
- 9. Block E (1953) A quantitative morphological investigation of the follicular system in newborn female infants. Acta Anatomica 17: 201–206. doi: 10.1159/000140805
- 10. Baker T (1963) A quantitative and cytological study of germ cells in human ovaries. Proceedings of the Royal Society of London Series B, Biological Sciences 158: 417–433. doi: 10.1098/rspb.1963.0055
- 11. Gougeon A, Chainey GBN (1987) Morphometric studies of small follicles in ovaries of women of different ages. Journal of Reproduction and Fertility 8: 433–442. doi: 10.1530/jrf.0.0810433
- 12. Richardson SJ, Senikas V, Nelson JF (1987) Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. Journal of Clinical Endocrinology and Metabolism 65: 1231–1237. doi: 10.1210/jcem-65-6-1231
- 13. Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, et al. (2008) A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Human Reproduction 23: 699–708. doi: 10.1093/humrep/dem408
- 14. Bendsen E, Byskov AG, Andersen CY, Westergaard LG (2006) Number of germ cells and somatic cells in human fetal ovaries during the first weeks after sex differentiation. Human Reproduction 21: 30–35. doi: 10.1093/humrep/dei280
- 15. Forabosco A, Sforza C (2007) Establishment of ovarian reserve: a quantitative morphometric study of the developing human ovary. Fertility and Sterility 88: 675–683. doi: 10.1016/j.fertnstert.2006.11.191
- 16. Bretherick KL, Fairbrother N, Avila L, Harbord SH, Robinson WP (2009) Fertility and aging: do reproductive-aged Canadian women know what they need to know? Fertility and Sterility, (in press, published online 17 March 2009). doi: 10.1038/ncb1869
- 17. Parent AS, Teilmann G, Juul A, Skakkebaek NE, Toppari J, et al. (2003) The timing of normal puberty and the age limits of sexual precocity: Variations around the world, secular trends, and changes after migration. Endocrine Reviews 24: 668–693. doi: 10.1210/er.2002-0019
- 18. Knight PG, Glister C (2006) TGF-beta superfamily members and ovarian follicle development. Reproduction 132: 191–206. doi: 10.1530/rep.1.01074
- 19. Broekmans FJ, Visser JA, Laven JS, Broer SL, Themmen AP, et al. (2008) Anti-Müllerian hormone and ovarian dysfunction. Trends in Endocrinolology and Metabolism 19: 340–347. doi: 10.1016/j.ijrobp.2004.11.038
- 20. Josso N, Lamarre I, Picard JY, Berta P, Davies N, et al. (1993) Anti-Müllerian hormone in early human development. Early Human Development 33: 91–99. doi: 10.1016/0378-3782(93)90204-8
- 21. Guibourdenche J, Lucidarme N, Chevenne D, Rigal O, Nicolas M, et al. (2003) Anti-Müllerian hormone levels in serum from human foetuses and children: pattern and clinical interest. Molecular and Cellular Endocrinology 211: 55–63. doi: 10.1016/j.mce.2003.09.011
- 22. Knauff EA, Eijkemans MJ, Lambalk CB, ten Kate-Booij MJ, Hoek A, et al. (2009) Anti-Müllerian hormone, inhibin B and antral follicle count in young women with ovarian failure. Journal of Clinical Endocrinology and Metabolism 94: 786–792. doi: 10.1210/jc.2008-1818
- 23. Younis JS, Jadaon J, Izhaki I, Haddad S, Radin O, et al. (2009) A simple multivariate score could predict ovarian reserve, as well as pregnancy rate, in infertile women. Fertility and Sterility (in press, published online 14 April 2009).
- 24. Wallace WHB, Kelsey TW (2004) Ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography. Human Reproduction 19: 1612–1617. doi: 10.1093/humrep/deh285
- 25. Brett S, Bee N, Wallace WHB, Rajkhowa M, Kelsey TW (2009) Individual ovarian volumes obtained from 2-dimensional and 3-dimensional ultrasound lack precision. Reproductive Biomedicine Online 18: 348–351. doi: 10.1016/S1472-6483(10)60092-2
- 26. Wallace WHB, Thomson AB, Kelsey TW (2003) The radiosensitivity of the human oocyte. Human Reproduction 18: 117–121. doi: 10.1093/humrep/deg016
- 27. Wallace WHB, Thomson AB, Saran F, Kelsey TW (2005) Predicting age at ovarian failure following radiation to a field that includes the ovaries. International Journal of Radiation Oncology*Biology*Physics 62: 738–744. doi: 10.1016/j.ijrobp.2004.11.038
- 28. Wallace WHB, Anderson RA, Irvine DS (2005) Fertility preservation for young patients with cancer: Who is at risk and what can be offered? Lancet Oncology 6: 209–218. doi: 10.1016/S1470-2045(05)70092-9